Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence (Q35124206)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence |
scientific article |
Statements
1 reference
Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence (English)
1 reference
T Peter Bridge
1 reference
Paul J Fudala
1 reference
Susan Herbert
1 reference
Deborah B Leiderman
1 reference
1 May 2003
1 reference
1 reference
70
1 reference
2 Suppl
1 reference
S79-85
1 reference
Identifiers
1 reference
1 reference